{"entity":{"id":"joaquin-martinez-lopez","kind":"person","name":"Joaquín Martínez-López","aka":[],"tldr":"Haematologist who heads the Haematology Department at Hospital 12 de Octubre and the joint H12O-CNIO haematological malignancies unit, known for myeloma and MRD research.","summary":"Joaquín Martínez-López is Head of the Haematology Department at Hospital Universitario 12 de Octubre in Madrid and heads the H12O-CNIO Haematological Malignancies Clinical Research Unit. His research centres on multiple myeloma, including minimal residual disease assessment and novel therapies. He is a professor at the Complutense University of Madrid.","asOf":"2026-09-10","links":[{"label":"Institution profile","url":"https://www.cnio.es/en/the-cnio/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Martinez-Lopez+J%5BAuthor%5D+myeloma"}],"tags":["clinician-scientist","haematology","multiple myeloma"],"related":[],"cancers":["multiple-myeloma","myeloproliferative-neoplasms"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["12-de-octubre"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":["blood-cancer-journal"],"dependsOn":[],"notes":[],"role":"Head of the Haematology Department","institutionId":"12-de-octubre","specialisms":["Multiple myeloma","Haematological malignancies","Minimal residual disease"],"profiles":[{"label":"Institution profile","url":"https://www.cnio.es/en/the-cnio/"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/?term=Martinez-Lopez+J%5BAuthor%5D+myeloma"}],"papers":[{"title":"Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma","journal":"Blood","year":2014,"doi":"10.1182/blood-2014-01-550020"},{"title":"Long-term prognostic significance of response in multiple myeloma after stem cell transplantation","journal":"Blood","year":2011,"doi":"10.1182/blood-2011-01-332320"},{"title":"Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality","journal":"Blood Cancer Journal","year":2020,"doi":"10.1038/s41408-020-00372-5"}],"orcid":"0000-0001-7908-0063"},"route":"/people/joaquin-martinez-lopez/","neighbours":{"cancer":[{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"},{"id":"myeloproliferative-neoplasms","kind":"cancer","name":"Myeloproliferative neoplasms (PV, ET, myelofibrosis)","route":"/cancers/myeloproliferative-neoplasms/"}],"institution":[{"id":"12-de-octubre","kind":"institution","name":"Hospital Universitario 12 de Octubre","route":"/institutions/12-de-octubre/"}],"journal":[{"id":"blood-cancer-journal","kind":"journal","name":"Blood cancer journal","route":"/journals/blood-cancer-journal/"}]}}